Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Cash flows from operating activities:
Net (loss)	$ (630,183)	$ (3,541,877)
Net (loss) income from discontinued operations	0	3,978
Net (loss) from continuing operations	(630,183)	(3,545,855)
Adjustments to reconcile net (loss) from continuing operations to cash (used in) provided by operating activities:
Depreciation and amortization	521,072	547,212
(Gain) on sale of assets	(14,124)	(9,250)
Allowance for doubtful accounts	20,808	(29,464)
Deferred financing costs / debt discount	124,770	614,226
Accrued deferred fee	0	260,700
Goodwill impairment	0	2,226,837
Changes in assets and liabilities:
Accounts receivable	474,990	1,425,104
Inventories	183,668	244,606
Other current assets	158,866	191,643
Accounts payable	(1,464,080)	1,425,759
Accrued payroll and commissions	(325,579)	(229,617)
Taxes accrued and withheld	26,168	71,111
Accrued expenses	(109,910)	(326,356)
Other liabilities	(150)	(450)
Net cash (used in) provided by operating activities continuing operations	(1,033,684)	2,866,206
Net cash provided by operating activities discontinued operations	31,546	135,119
Net cash provided by operating activities	(1,002,138)	3,001,325
Cash flows from investing activities:
Purchase of property and equipment	(129,634)	(73,600)
Proceeds from sale of fixed assets	45,552	9,250
Proceeds from assets held for sale	0	816,667
Change in other assets	1,293	(538)
Net cash (used in) provided by investing activities continuing operations	(82,789)	751,779
Net cash provided by investing activities discontinued operations	0	408,333
Net cash provided by (used in) investing activities	(82,789)	1,160,112
Cash flows from financing activities:
Proceeds from term debt	108,623	0
Principal payments on term debt	(249,082)	(1,832,508)
Net cash used in financing activities continuing operations	(140,459)	(1,832,508)
Net cash used in financing activities discontinued operations	0	(408,333)
Net cash used in financing activities	(140,459)	(2,240,841)
Net (decrease) increase in cash and cash equivalents	(1,225,386)	1,920,596
Cash and cash equivalents at beginning of period	1,428,542	1,844,797
Cash and cash equivalents at end of period	$ 203,156	$ 3,765,393